Immunetech
Executive Summary
Transfers R&D labs to Tanabe. The company also announced that it has acquired Tampa-based Thera Tec, manufacturer of nebulization systems marketed by Immunetech-subsidiary Dura Pharmaceuticals. The deals "will continue Immunetech's planned change from a research company to an operating pharmaceutical business," the company said. Immunetech retains all rights to its anti-allergy peptide Pentyde. NDA's for Pentyde Nasal Spray, Pentyde Injectable and Pentyde Ophthalmic are pending at FDA.